QCM
EW icon

Qsemble Capital Management’s Edwards Lifesciences EW Stock Holding History

Qsemble Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$333K Buy
+3,686
New +$309K 0.04% 326
2024
Q4 		– Sell
-63,284
Closed -$4.18M – 435
2024
Q3 		$4.18M Buy
+63,284
New +$4.6M 0.77% 34
2023
Q4 		– Sell
-3,900
Closed -$270K – 392
2023
Q3 		$270K Buy
+3,900
New +$313K 0.05% 294

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Qsemble Capital Management's EW Position: Q2 2026 in Review

Qsemble Capital Management opened a new position in Edwards Lifesciences (EW) in Q2 2026: 3,686 shares worth $333K. The stake represents 0.04% of the portfolio and ranks #326 among its holdings. This is a return to the name: Qsemble Capital Management previously reported a position in EW as recently as Q3 2024.

Qsemble Capital Management first reported a position in EW in Q3 2023 and has held it in 3 quarters since. The position peaked at $4.18M in Q3 2024. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Qsemble Capital Management held 3,686 shares of Edwards Lifesciences worth $333K as of Q2 2026.
  • Edwards Lifesciences was a new Qsemble Capital Management position in Q2 2026.
  • Edwards Lifesciences made up 0.04% of Qsemble Capital Management's portfolio in Q2 2026, its #326 holding.
  • Qsemble Capital Management first reported a position in Edwards Lifesciences in Q3 2023 and has held it in 3 quarters since.
  • Qsemble Capital Management's Edwards Lifesciences position peaked at $4.18M in Q3 2024.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Qsemble Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.